CTX-2026 是一种纯人源抗体，与 CD277 结合。CTX-2026 在卵巢肿瘤模型中显示抗肿瘤作用。CTX-2026 可用于癌症的研究。

For Powder, reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.

本产品仅用作科学研究！

Anti-BTN3A1 Reference Antibody (CTX-2026) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

The purity of Anti-BTN3A1 Reference Antibody (CTX-2026) is 98.77%, determined by SEC-HPLC.

Immobilized human PVRIG His at 2 ug/mL can bind Anti-BTN3A1 Reference Antibody (CTX-2026), EC50=0.002394 ug/mL.

Human BTN3 HEK293 cells were stained with Anti-BTN3A1 Reference Antibody (CTX-2026) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.8254 nM.

Anti-BTN3A1 Reference Antibody（CTX-2026）captured on CM5 chip via anti-human IgG Fc antibodies surface, can bind Human BTN3A1 / BTF5 / CD277, His Tag (Cat. PHA276) with an affinity constant of 9.89E-11M as determined in a SPR assay

-80°C for 2 years under sterile conditions；-20°C for 1 year under sterile conditions；Avoid repeated freeze-thaw cycles.